Hundreds of people in England with aggressive blood cancer are set to benefit from an innovative new treatment that ...

People with a form of blood cancer are living almost twice as long on average compared to 20 years ago, according to a study. However, experts warned survival for multiple myeloma “remains ...

LLS’s Investment in Leading-Edge Research Aims to Accelerate Treatment Innovation and Expand Equitable Access to Treatments to Increase the Quality of Life and Survival Rates for All Blood Cancer ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on the ...